Resting coronary flow and coronary flow reserve in human infants after repair or palliation of congenital heart defects as measured by positron emission tomography  by Donnelly, Jon P. et al.
RESTING CORONARY FLOW AND CORONARY FLOW RESERVE IN HUMAN INFANTS AFTER
REPAIR OR PALLIATION OF CONGENITAL HEART DEFECTS AS MEASURED BY POSITRON
EMISSION TOMOGRAPHY
Jon P. Donnelly, MD
David M. Raffel, PhD
Barry L. Shulkin, MD
James R. Corbett, MD
Edward L. Bove, MD
Ralph S. Mosca, MD
Thomas J. Kulik, MD
Objective: Coronary physiology in infants with congenital heart disease
remains unclear. Our objective was to better understand coronary physi-
ology in infants with congenital heart disease. Methods: We used positron
emission tomography with nitrogen 13–labeled ammonia to measure myo-
cardial perfusion at rest and with adenosine (142 mg/kg/min 3 6 minutes)
in five infants after anatomic repair of a congenital heart lesion (group I),
and in five infants after Norwood palliation for hypoplastic left heart
syndrome (group II). The groups were matched for age, weight, and time
from the operation. Results: Resting coronary flow in the left ventricle in
group I was 1.8 6 0.2 ml/min/gm; resting flow in the right ventricle in group
II was 1.0 6 0.3 ml/min/gm (p 5 0.003). Coronary flow with adenosine was
2.6 6 0.5 ml/min/gm in group I and 1.5 6 0.7 ml/min/gm in group II (p 5
0.02). Absolute coronary flow reserve was the same in both groups (1.5 6
0.2 in group I vs 1.6 6 0.3 in group II, p 5 0.45). Oxygen delivery was
reduced in group II compared with group I at rest (16.1 6 4.2 ml/min/100
gm vs 28.9 6 4.42 ml/min/100 gm, p 5 0.02) and with adenosine (25.5 6 8.1
ml/min/100 gm vs 42.3 6 5.8 ml/min/100 gm, p 5 0.02). Conclusions: Infants
with repaired heart disease have higher resting flow and less coronary flow
reserve than previously reported for adults. After Norwood palliation,
infants have less perfusion and oxygen delivery to the systemic ventricle
than do infants with a repaired lesion. This may in part explain why the
outcome for patients with Norwood palliation is less favorable than for
others. (J Thorac Cardiovasc Surg 1998;115:103-10)
The heart has an inordinately high rate of oxygenconsumption compared with other, less metaboli-
cally active organs. Adequate oxygen is supplied to the
myocardium under varying physiologic conditions
through regulation of coronary artery flow. The extent
to which coronary blood flow can be increased above
resting flow, as is seen during reactive hyperemia or
adenosine infusion, is termed coronary flow reserve.1
Coronary flow reserve is commonly expressed as cor-
onary flow during maximal coronary vasodilatation
divided by resting flow.2, 3 In the adult human heart,
left ventricular myocardial perfusion can be increased
fourfold relative to resting perfusion with maximal
coronary dilatation.4, 5 Little is known about myocar-
dial perfusion in the infant heart, although studies
performed in late-gestation fetuses and newborn
lambs suggest that infants have a coronary flow at rest
that is twice the adult value.6 The degree to which
neonates can increase myocardial blood flow with
maximal coronary dilatation is unknown, and there are
no published reports quantifying coronary flow or
coronary flow reserve in human infants.
Infants with certain types of structural heart dis-
ease may be at risk for diminished resting flow or
coronary flow reserve, and this may become clini-
cally important when myocardial oxygen demand
increases acutely. Infants with hypoplastic left heart
system (HLHS) after Norwood palliation may be at
Department of Pediatrics, Division of Pediatric Cardiology;
Department of Surgery, Division of Pediatric Cardiovascular
Surgery; and Department of Internal Medicine, Division of
Nuclear Medicine; University of Michigan, Ann Arbor, Mich.
Supported by funds from the National Institutes of Health
through a grant from the Clinical Research Center at the
University of Michigan Medical Center.
Received for publication March 25, 1997; revisions requested July
8, 1997; revisions received July 30, 1997; accepted for publi-
cation August 8, 1997.
Address for reprints: Thomas J. Kulik, MD, University of Michigan
Hospitals, MCHC F1310, Box 0204, Ann Arbor, MI 48109-0204.
Copyright © 1998 by Mosby, Inc.
0022-5223/98 $5.00 1 0 12/1/85371
1 0 3
particularly high risk for coronary insufficiency.
There is a large diastolic runoff from the neoaorta
into the pulmonary arteries through the modified
Blalock-Taussig shunt, creating diminished diastolic
perfusion pressure for the coronary circulation. Ox-
ygen consumption is increased in the volume- and
pressure-loaded right ventricle. There is a potential
for proximal coronary artery constriction as a result
of the technically complex neoaortic reconstruction.
This study used positron emission tomography
(PET) to measure resting coronary flow and coro-
nary flow reserve in human infants who had ana-
tomic repair of a congenital heart lesion. The data
were used to determine whether infants with HLHS
after Norwood palliation have altered myocardial
perfusion or coronary flow reserve compared with
those with completely repaired congenital cardiac
defects.
Methods
Subjects. Group I subjects were five infants who under-
went complete surgical repair of structural heart defects
that are not thought to be associated with limited myo-
cardial perfusion (Table I). Group II consisted of five
infants with HLHS who underwent stage-one palliation
within the first 17 days after birth. Each of these infants
received a 3.5 mm modified Blalock-Taussig shunt from
the right innominate artery to the pulmonary artery
bifurcation as part of their operative procedure.7 The
diagnosis of HLHS was made by transthoracic echocardi-
ography and was defined as mitral and aortic hypoplasia
or atresia in the presence of a non–apex-forming left
ventricle. All group II patients had the echocardiographic
diagnosis of HLHS made in utero or soon after birth, so
that ductal patency was maintained with prostaglandin E1
and no patient had been in hemodynamically unstable
condition before the operation. Likewise, group I patients
had diagnosis by transthoracic echocardiography in the
neonatal period and were in hemodynamically stable
condition before the operation. Postoperative echocardio-
grams revealed all but one patient to be free of residual
lesions (one of the group II patients had moderate
tricuspid regurgitation). Both groups were in clinically
stable condition and doing well when they were studied.
Two of five group I patients and three of five group II
patients were receiving maintenance digoxin therapy
when they were studied. No patient was receiving mechan-
ical ventilation or intravenous inotropic or vasoactive
support when studied. Patient selection was driven pri-
marily by parental willingness for their child to participate
and availability of the PET scanner. Although the patients
were not chosen randomly from among all those under-
going similar operations at our institution, we consider
them representative of this population. The protocol was
approved by the Institutional Review Board and the
Subcommittee for the Use of Radioisotopes in Human
Subjects at the University of Michigan. The parents of
each patient gave written and informed consent before
enrollment in the study.
Adenosine infusion. To measure coronary flow reserve,
the infants received a continuous intravenous infusion of
adenosine (Adenocard, Fujisawa USA, Deerfield, Ill.) at a
dose of 142/mg/kg/min for 6 minutes. Previous dose-
response testing in adults has determined this to be the
lowest dose that provides maximal coronary dilatation and
myocardial perfusion.8 Although continuous adenosine
infusions have been administered to adults for the treat-
ment of pulmonary hypertension,9, 10 there are no re-
Fig. 1. ROIs within the systemic ventricular wall for (A) infants with HLHS after Norwood palliation
(group II), and (B) infants with repaired structural heart disease (group I). RV, Right ventricle; LV, left
ventricle; Inf-sept, inferoseptal; Ant-sept, anteroseptal; Ant-lat, anterolateral; Inf-lat, inferolateral.
The Journal of Thoracic and
Cardiovascular Surgery
January 1998
1 0 4 Donnelly et al.
ported cases of continuous adenosine infusions in infants.
We therefore administered a test infusion 1 day before the
study while the infants were closely monitored in an
intensive care setting to ensure that the medication would
be tolerated. Heart rate, blood pressure, and oxygen
saturations were measured at baseline and throughout the
infusion.
PET. All patients received chloral hydrate (100 mg/kg
orally) before being transported to the PET scanning
suite. Patients were spontaneously breathing and asleep
before being placed within the PET camera (Siemens CTI
931; Siemens, Knoxville, Tenn.) with the heart centered in
the middle of the field of view. A brief transmission scan
was performed for attenuation correction before injection
of 4 mCi nitrogen 13-labeled ammonia intravenously
during 30 seconds.
Images were then acquired dynamically for 15 minutes.
Approximately 45 minutes later, after decay of the nitro-
gen 13 activity, patients underwent adenosine infusion to
determine maximal coronary flow. Three minutes after
the start of the infusion, the subjects received 4 mCi
nitrogen 13-labeled ammonia intravenously during 30
seconds. The adenosine infusion was continued for a total
of 6 minutes, and images were repeated.
Myocardial flow was measured in 16 ventricular re-
gions. The ventricular wall was divided into four regions of
interest (ROIs) in four contiguous, short-axis slices cov-
ering the distal and proximal regions of the ventricle (Fig.
1). For each ROI, time-activity data were generated for
compartmental modeling of the nitrogen 13-labeled am-
monia kinetics. The time-activity curves were fit into a
three-compartment model for quantification of regional
and global myocardial flow as previously described else-
where.11, 12 All flows are expressed in milliliters per
minute per gram of tissue. Only flow to the systemic
ventricle (left ventricle in group I and right ventricle in
group II) was measured and analyzed for comparison.
Group I infants had minimal retention of nitrogen 13-
labeled ammonia within their right ventricular myocar-
dium, making it difficult to distinguish myocardial flow
from the tracer found within the blood pool. Conse-
quently, the morphologically right ventricles could not be
compared between groups.
Regional flows were compared for each group at rest
and during an adenosine infusion to determine whether
flows are preferentially distributed during adenosine hy-
peremia. The left ventricles of group I patients were
divided into regions designated as inferior, lateral, anterior,
and septal. The systemic right ventricles of group II
patients were divided into four ROIs with the following
designations: anteroseptal, anterolateral, inferoseptal, and
inferolateral, with septal referring to the right ventricular
myocardium separating the right ventricular cavity from
the hypoplastic left ventricular chamber (Fig. 1).
Oxygen delivery to the myocardial tissue was calculated
for both groups by multiplying the oxygen content of the
blood (milliliters of oxygen per liter of blood) by the flow
(milliliters per minute per 100 gm of tissue) and is
expressed in milliliters per minute per 100 gm of tissue.
Oxygen carrying capacity was calculated by multiplying
each patient’s hemoglobin level (measured within 24
hours of the study) by the oxygen carrying capacity of 1 gm
hemoglobin (13.6 ml/L). The oxygen saturation measured
during the resting portion of the PET scan (with a Nellcor
pulse oximeter, Nellcor, Inc., Hayward, Calif.) was multi-
plied by the oxygen carrying capacity to determine oxygen
content.
Statistical analysis. Global myocardial flows between
groups were compared with an unpaired Student’s t test.
When reporting regional flows, values for each of the four
contiguous slices were averaged within each ROI. Mean
regional flows at rest were then compared with those
during adenosine for patients within groups by means of a
paired t test. For comparisons of hemodynamic data,
Student’s t tests were computed to compare groups at
each time during the adenosine infusion, comparisons
between each subsequent time and baseline were com-
puted within each group separately by means of paired t
Table I. Patient characteristics
Patient Diagnosis Sex Age (days) Weight (kg) Postop (days) Hb O2 Sat
Group I
1 VSD F 89 2.79 10 14.1 95
2 PA/VSD M 9 3.26 7 11.8 89
3 Discont. PAs F 46 3.47 5 14.3 94
4 IAA/VSD M 23 3.17 11 11.0 92
5 D-TGA M 27 3.15 13 13.4 98
Mean 6 SD 38.8 6 31.0 3.17 6 0.24 9.2 6 3.2 12.9 6 1.4 93.6 6 3.4
Group II
1 HLHS (MA) F 16 3.43 9 15.2 76
2 HLHS (MA) F 26 3.79 15 17.1 82
3 HLHS (MH) M 26 3.35 9 16.8 72
4 HLHS (MA) M 18 3.89 11 17.2 83
5 HLHS (MH) M 26 3.20 22 14.0 77
Mean 6 SD 22.4 6 5.0 3.53 6 0.30 13.2 6 5.5 16.1 6 1.4 78.0 6 4.5
p Value 0.28 0.07 0.20 0.008 0.0003
Hb, Blood hemoglobin; O2 Sat, systemic arterial oxygen saturation; VSD, ventricular septal defect; PA/VSD, pulmonary atresia with ventricular septal defect;
Discont PAs, discontinuous pulmonary arteries; IAA/VSD, interrupted aortic arch with a ventricular septal defect; D-TGA, dextrotransposition of the great
arteries; SD, standard deviation; MA, mitral atresia; MH, mitral hypoplasia; Postop, time after the operation that the PET study was performed.
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tests, and overall analyses to assess both group and time
variations simultaneously were computed by means of the
two-factor analysis of variance for repeated measures
(profile analysis).
Results
Adenosine infusion. All patients tolerated both
the trial infusion of adenosine and the adenosine
infusion during the PET scan without difficulty.
Mean systolic blood pressures fell during the aden-
osine infusion by 16% in group I (77 vs 65 mm Hg;
p 5 0.03) and 13% in group II (78 vs 68 mm Hg; p 5
0.07) and mean diastolic blood pressures fell by 24%
in group I (49 vs 37 mm Hg; p 5 0.004) and 14% in
group II (36 vs 31 mm Hg; p 5 0.19). The mean
heart rate increased by 16% in group I (128 vs 149
beats/min; p 5 0.003) and 8% in group II (130 vs 141
beats/min; p 5 0.03) during the adenosine infusion.
There was no difference in systolic blood pressure or
heart rate between groups at baseline or at any time
during the infusion. Group II infants had signifi-
cantly lower diastolic blood pressures at baseline
than did group I infants, which probably reflects the
diastolic runoff through the Blalock-Taussig shunt
(p 5 0.02). Both groups had a drop in diastolic
blood pressure during adenosine infusion, with sig-
nificant differences between groups occurring during
the first half of the infusion. After 3 minutes, infants
in group I had diastolic pressures similar to those in
group II. Diastolic blood pressures returned to
baseline in both groups within 3 minutes of discon-
tinuation of the adenosine and were again lower in
the group II infants (p 5 0.07).
Coronary flow and flow reserve. Fig. 2 demon-
strates the myocardial uptake of nitrogen 13-labeled
ammonia at rest and during the adenosine infusion
in one patient from each group. Flow to the systemic
right ventricle of group II infants was significantly
increased compared with flow to the pulmonary
Fig. 2. Examples of four contiguous, short-axis images of myocardial nitrogen 13-labeled ammonia uptake
at rest (upper row) and during adenosine infusion (stress) in (A) a patient with dextrotransposition of the
great arteries after an arterial switch operation and (B) a patient with HLHS after Norwood palliation.
Images are displayed from the apex to the base of the heart. Note the intense signal within the hypoplastic
left-ventricle in B. LV, Left ventricle; RV, right ventricle.
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right ventricle of group I infants (although the small
amount of tracer uptake in the latter did not permit
quantitative comparison).
Group II infants had significantly less flow to their
systemic (right) ventricle at rest than did group I
infants (p 5 0.003). Measured flows during adeno-
sine infusion were also greater in group I (p 5 0.02),
although the percentage increases were similar, so
that coronary flow reserve was not statistically dif-
ferent (p 5 0.45; Table II). When oxygen delivery to
the systemic ventricle was compared between
groups, group II infants had significantly less deliv-
ered oxygen per 100 gm tissue than did group I
infants, both at rest (p 5 0.002) and during adeno-
sine hyperemia (p 5 0.02; Table II).
When regional flows were analyzed for each
group (Table III), group I infants had greater flow to
the lateral region of their left ventricle at rest (p 5
0.01), with all other regions being similar between
groups. During adenosine hyperemia, the lateral
region again received significantly more flow than
did all other regions (p 5 0.04) except the anterior
region (p 5 0.08). There was therefore no difference
in calculated coronary flow reserve among regions in
group I. Group II infants had preferential flow to
the septal regions of the right ventricle at rest (p 5
0.01 vs lateral regions). During stress, greater in-
creases in flow were seen in the lateral regions, so
there were no regional differences in myocardial
flow with adenosine hyperemia. Coronary flow re-
serve was calculated to be significantly higher in the
anterolateral region (p # 0.04 vs septal regions),
whereas the mean reserve in the inferolateral region
was similar to those in the septal regions.
Discussion
Coronary flow has been difficult to study in human
infants because of the lack of a reliable and nonin-
vasive means of measuring myocardial perfusion.
PET, however, has become an experimentally vali-
dated and clinically accepted method of measuring
coronary flow in adults.2-5, 13 We therefore used this
modality to investigate coronary flow and flow re-
serve in the human infant. Our findings indicate that
PET provides technically acceptable imaging of
myocardial perfusion in the human infant despite
the small size of the heart. The application of this
technique to the human infant allows, for the first
time, accurate quantitation of myocardial perfusion
in this group of patients.
PET quantitation of resting myocardial perfusion
in group I infants (1.8 6 0.2 ml/min/gm) was higher
than that measured by Chan and colleagues4 in
healthy, adult volunteers (1.1 6 0.2 ml/min/gm, n 5
20, p 5 0.0003). Higher coronary flow at rest in
infants is consistent with data from experiments
performed in sheep.6 Moreover, neonates have
higher heart rates and metabolic rates than do
adults, both of which would predispose them toward
higher coronary flows at rest.14 Maximal myocardial
Table II. Myocardial flow and oxygen delivery to the systemic ventricle
Patient
Myocardial flow (ml/min/gm) Oxygen delivery (ml/min/100 gm)
Rest *Stress Reserve Rest *Stress
Group I
1 1.40 6 0.42 2.10 6 0.29 1.59 6 0.37 25.50 38.25
2 1.82 6 0.75 2.60 6 0.70 1.52 6 0.26 25.99 37.14
3 1.84 6 0.70 2.40 6 1.03 1.30 6 0.23 33.27 43.87
4 1.85 6 0.34 2.41 6 0.71 1.29 6 0.22 25.46 33.17
5 1.91 6 0.70 3.30 6 1.77 1.67 6 0.63 34.11 58.94
Mean 6 SD 1.76 6 0.19 2.56 6 0.41 1.47 6 0.15 28.87 6 3.98 42.27 6 9.07
CI90 1.58-1.95 2.16-2.97 1.32-1.63 24.88-32.85 33.20-51.35
Group II
1 0.67 6 0.17 1.34 6 0.28 2.04 6 0.30 10.53 21.05
2 0.88 6 0.28 1.37 6 0.29 1.57 6 0.53 16.78 26.12
3 0.94 6 0.20 1.26 6 0.47 1.32 6 0.38 15.46 20.72
4 0.79 6 0.14 1.03 6 0.23 1.31 6 0.25 15.34 20.00
5 1.51 6 0.22 2.69 6 0.69 1.77 6 0.28 22.14 39.44
Mean 6 SD 0.96 6 0.29 1.54 6 0.59 1.60 6 0.28 16.05 6 3.74 25.47 6 7.37
CI90 0.66-1.25 0.95-2.13 1.32-1.88 12.31-19.79 18.03-32.84
p Value 0.003 0.02 0.45 0.02 0.02
SD, Standard deviation; CI90 , 90% confidence interval.
*Stress represents values obtained during adenosine infusion at 142 mg/kg/min; p values represent group I vs group II.
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perfusion in group I infants (2.6 6 0.5 ml/min/gm)
was significantly less than that found in adults (4.4 6
0.9 ml/min/gm), as determined with identical aden-
osine dosing and imaging techniques (p , 0.0001).
Group I patients therefore had a coronary flow
reserve only 37% that of adults, suggesting that
infants may be less able to maximally increase
myocardial blood flow at times of increased oxygen
demand. There are, however, several factors that
need to be taken into account when interpreting
these data.
First, group I patients were not truly healthy; they
had structurally abnormal hearts at birth. However,
they all underwent complete surgical repair and had
no echocardiographic or clinical evidence of altered
hemodynamics at the time that they were studied. In
addition, neither the original cardiac lesion nor the
surgical repair should cause myocardial perfusion to
differ in these patients from that in infants with
normal cardiac anatomy at birth. Three of the
control infants had a ventricular septal defect re-
paired with a polytetrafluoroethylene (PTFE)
patch,* resulting in relatively less perfusable septal
myocardium. Because the defects were located high
in the ventricular septum, however, it is unlikely that
the axial sections analyzed extended into this region,
and when septal perfusion in these patients was
compared with that of infants who had intact septa,
there was no difference at any level of imaging
within the ventricular septum. One of the infants in
group I underwent an arterial switch procedure for
dextrotransposition of the great arteries. Although
the potential exists for coronary artery obstruction
after this operation, few patients have clinically
apparent postoperative impairment in coronary
flow. Tanel and colleagues15 reviewed postoperative
angiograms performed on 366 healthy patients who
underwent the arterial switch operation for transpo-
sition of the great arteries. Only 13 patients (3%)
had abnormalities of their coronary arteries by
angiography.
Second, these infants had undergone cardiac op-
erations and cardiopulmonary bypass, which have
been related to acute myocardial and vascular dys-
function. Ischemia during aortic crossclamping,16
inadequate myocardial protection with hypothermia
and cardioplegic solutions,17 and reperfusion inju-
ry18, 19 may all contribute to acute myocyte dysfunc-
tion after cardiac operations. This has direct impli-
cations for this study because retention of nitrogen
13-labeled ammonia in myocardium represents a
combination of delivery (coronary flow) and meta-
bolic incorporation. However, except for the clinical
entity of “stunned myocardium,” in which depressed
myocardial function is apparent clinically and often
protracted, the metabolic and functional alterations
associated with cardiopulmonary bypass are tran-
sient and have been demonstrated to be reversible
within 48 hours after the operation.20-22 Our pa-
tients all exhibited good cardiac function after their
operations and were studied well beyond 48 hours,
making it unlikely that cardiopulmonary bypass in-
fluenced our results. Endothelial dysfunction has
also been demonstrated after cardiopulmonary by-
pass and could potentially affect both resting flows
and the vascular response to adenosine.23, 24 It is
unclear whether this factor could have played a
significant role in our studies.
A third consideration relates to the use of aden-
osine as a coronary vasodilator. This nucleotide
activates specific receptors on endothelial and
smooth muscle cell membranes in the coronary
circulation to cause vasodilation.25 Although dose-
response testing has determined that approximately
140 mg/kg/min is the optimal dose for maximal
coronary dilatation in adults,8 similar studies have
not been performed in infants. It is therefore possi-
ble that the dose used in this study did not maxi-
mally dilate the coronary vessels in our infants.
Unfortunately, because the difficult task of inhibit-
ing patient movement limits the time available for
*Gore-Tex patch, registered trade name of W. L. Gore &
Associates, Inc., Newark, Del.
Table III. Mean regional myocardial flow to the systemic ventricle
Rest (ml/min/gm) Stress* (ml/min/gm)
1 2 3 4 1 2 3 4
Group I 1.39 6 0.44 1.87 6 0.43 1.38 6 0.46 1.09 6 0.43 2.02 6 0.54 2.29 6 0.48 2.05 6 0.28 1.67 6 0.40
Group II 1.04 6 0.27 1.04 6 0.16 0.85 6 0.21 0.94 6 0.29 1.52 6 0.54 1.67 6 0.25 1.63 6 0.31 1.55 6 0.80
Regions are as follows: 1, Inferior in group I and inferoseptal in group II; 2, lateral in group I and anteroseptal in group II; 3, anterior in group I and
anterolateral in group II; 4, septal in group I and inferolateral in group II.
*Stress represents values obtained during adenosine infusion at 142 mg/kg/min; p values represent group I vs group II.
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study, the development of a full dose-response curve
for adenosine would be difficult or impossible with
spontaneously breathing infants. It is also possible
that the vasodilatory response to adenosine may be
incompletely developed in the neonatal period,
making an adenosine infusion inappropriate to de-
termine myocardial flow reserve in infants.
Finally, at least some of the patients in group I
may have had left ventricular hypertrophy as a result
of volume or pressure overload. Myocardial hyper-
trophy can reduce coronary flow reserve, which may
also account for the reduced reserve in these pa-
tients relative to healthy adults. It should be noted,
however, that the immature heart appears to main-
tain myocardial flow reserve with hypertrophy better
than does the adult heart,14 which tends to militate
against myocardial hypertrophy as an explanation
for reduced coronary flow reserve in these infants.
We also investigated myocardial flow in a group
of infants whose anatomy and physiology may pre-
dispose them toward limited myocardial perfusion.
Our findings suggest that infants with HLHS after
Norwood palliation have less resting and maximal
flow (and oxygen delivery) to their systemic ventricle
than do infants who have undergone anatomic re-
pair of a heart defect. The diminished myocardial
flow at rest is perhaps surprising in light of the fact
that the systemic ventricle in infants with HLHS
after Norwood palliation performs increased vol-
ume work as a result of supporting both the systemic
and pulmonary circulations. The baseline heart rates
were nearly identical for each group (130 6 11 vs
128 6 13 beats/min, p 5 0.9), indicating that a
reduction in diastolic perfusion time was not a
significant factor. It is possible that the difference in
resting flows between the two groups relates to
disproportionate flow to the diminutive yet hyper-
trophied left ventricle of patients with HLHS. Al-
though the left ventricle performs no useful work, it
continues to consume significant coronary artery
flow, as demonstrated by intense tracer uptake in
Fig. 2, B. It is also possible that total coronary artery
flow is limited by the anatomy of the neoaorta and
that flow to the left ventricle, in effect, “steals”
coronary flow from the right ventricular myocar-
dium. Another possible explanation for the dimin-
ished coronary flow in the group II patients is that
intrinsic abnormalities of the coronary arteries are
responsible for the reduction in both resting and
maximal coronary flow seen in group II relative to
group I patients. Several investigators have de-
scribed an increased prevalence of coronary-cam-
eral communications in patients with HLHS, espe-
cially those with mitral hypoplasia and aortic
atresia.26, 27 No coronary-cameral communications
could be appreciated by color-Doppler imaging in
any of our patients, although this technique is
probably an insensitive method of detecting small
sinusoidal communications. In a histologic study of
the coronary vessels, Sauer and colleagues28 de-
scribed fibroelastic thickening of the intima with
fragmentation and duplication of the internal elastic
lamina in nine of 26 patients with HLHS. All but
one of these patients had mitral hypoplasia and
aortic atresia, suggesting that this subgroup of pa-
tients may be at higher risk for impaired myocardial
perfusion. Also worth considering is the fact that
coronary flow is influenced by arterial oxygen satu-
ration and hemoglobin concentration.14 It is difficult
to estimate the net impact of these factors on the
differential between group I and II myocardial flows.
Group II patients had higher resting hematocrits
than those in group I (which would tend to reduce
flow) but lower arterial saturations (which would
tend to increase myocardial flow). Finally, with the
vasodilator adenosine, systemic diastolic pressure
fell to 31 mm Hg in group II patients, which may be
at or near the level where coronary perfusion be-
comes pressure dependent. If so, coronary blood
flow with adenosine in the patients with HLHS may
have been limited in part because of reduced driving
pressure as a result of the adenosine.
The subject of myocardial perfusion in human
infants is becoming more important as medical and
surgical advances improve outcome for children
with complex structural heart disease. Despite a
marked improvement in survival for children with
HLHS,7 there continue to be unexpected deaths
after Norwood palliation. In addition, Schwartz29
and colleagues demonstrated an increase in collagen
within the right ventricular myocardium of infants
with HLHS at autopsy. Limited coronary artery
reserve coupled with reduced oxygen delivery to the
ventricular myocardium may predispose toward
Reserve
1 2 3 4
1.51 6 0.32 1.42 6 0.30 1.58 6 0.30 1.62 6 0.43
1.48 6 0.42 1.65 6 0.39 1.96 6 0.22 1.61 6 0.52
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ischemic damage, which may be seen acutely as
sudden death or as progressive ventricular fibrosis
and dysfunction. Further studies with PET imaging
of myocardial perfusion should provide a broader
understanding of myocardial perfusion in patients
with HLHS and other types of structural heart
disease.
Anthony Schork, PhD, provided assistance with the
statistical analysis. We acknowledge Diane Gaffney, RN,
for her assistance with patients during the study.
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